• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Bulking agent for female SUI receives approvable letter

Article

Uroplasty, Inc. has received an approvable letter from the FDA relating to its pre-market approval application for Macroplastique implants for the treatment of female stress urinary incontinence.

Uroplasty, Inc. has received an approvable letter from the FDA relating to its pre-market approval application for Macroplastique implants for the treatment of female stress urinary incontinence.

The product is a soft tissue, injectable bulking agent for use in a minimally invasive, outpatient procedure. When a physician injects Macroplastique into the tissues surrounding the urethra, the increased bulk allows the urethra to close more effectively and prevents urine from leaking, the company said.

Related Content
© 2024 MJH Life Sciences

All rights reserved.